申请人:Pharmacia & Upjohn Company
公开号:US05952324A1
公开(公告)日:1999-09-14
Phenyloxazolidinone compound of formula (I)or a pharmaceutically acceptable salt thereof characterized by a bicyclic thiazine or oxazine substituent. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria such as multiply-resistant staphylococci, streptococci and enterococci as well as anaerobic organisms such as Bacteroides spp. and Clostridia spp. species, and acid-fast organisms such as Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium spp.
式(I)的苯基噁唑烷酮化合物或其药学上可接受的盐,其特征是具有双环噻嗪或噁唑基团。这些化合物是有用的抗微生物剂,对多种人类和兽医病原体具有有效作用,包括革兰氏阳性厌氧细菌,如多重耐药葡萄球菌、链球菌和肠球菌,以及厌氧生物,如Bacteroides属和Clostridia属物种,以及耐酸生物,如结核分枝杆菌、分枝杆菌和分枝杆菌属。